Skip to main content
logo
Biodyne Co., Ltd. (KOSDAQ:314930)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,080.00
-60.00 (-0.98%)
At close: Oct 21, 2026

Biodyne Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Revenue
5,7747,0285,271
Revenue Growth
-33.32%-
Gross Profit
3,5214,4682,438
Operating Income
77.13652.26-1,730
Net Income
1,223851.5910.77
Earnings Per Share
40.8928.890.37
EPS Growth
-7806.90%-

Revenue by Geography
Chart
Fiscal Year
TTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Korea
1,025997.241,177
Europe
2,8403,1951,657
Japan
1,4102,0351,703
Other
498.9800.7733.95
Total
5,7747,0285,271

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Cash & Investments
14,75315,98120,713
Total Debt
6.3311.0412.07
Net Cash (Debt)
14,74715,97020,701
Net Cash Growth
--22.86%-
Net Cash Per Share
500.29541.77702.30

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Operating Cash Flow
1,211830.26877.41
Capital Expenditures
-4,079-3,431-539.15
Free Cash Flow
-2,869-2,601338.26
Free Cash Flow Growth
---

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Gross Margin
60.97%63.57%46.25%
Operating Margin
1.34%9.28%-32.81%
Pretax Margin
20.79%11.83%-2.68%
Profit Margin
21.18%12.12%0.20%
FCF Margin
-49.68%-37.01%6.42%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024
Period EndingOct '26 Dec '25 Dec '24
PE Ratio
148.69471.8444493.04
Forward PE
34.45110.44175.00
P/FCF Ratio
--1416.66
PS Ratio
31.0457.1890.91